Muscarinic acetylcholine receptors consist of five genetic subtypes that mediate signal transduction by coupling with G-proteins. The structures of G-protein-coupled receptors are not known in detail, as no high resolution structural information is available from physical measurements. These receptors are known to be integral membrane proteins, that have seven hydrophobic regions that form seven transmembrane (TM) domains (TM1-TM7) connected by three outer (o1-o3) and three intracellular loops (i1-i3). Studies will a variety of mutant receptors have indicated that the amino acids adjacent to the TM domains on the intracellular face are essential for G-protein coupling. Studies with chimeric receptors have implicated both the i2 and i3 loops in defining the selectivity of receptors for distinct G-proteins. And in the case of muscarinic receptor subtypes, amino acids on the N-terminal side of the i3 loop (Ni3) are critical determinants that define subtype preferences for the G-proteins Gq versus Gi. In the case of the alpha adrenergic receptors, amino acids in the c- terminal region of the i3 loop (Ci3) have been implicated in receptor activation and allosteric regulation of agonist binding. To gain insight into the structural requirements of receptor/G-protein coupling, we will subject the i2, Ni3 and Ci3 regions of the m5 muscarinic receptor to random-saturation mutagenesis. Mutant muscarinic receptors with a variety of functional phenotypes will be identified by screening all recombinants via rapid functional assays that we have developed. Our screens are designed to identify the range of amino acid substitutions that allow retention of overall receptor function, activate the receptor in the absence of agonist, change the affinity of the receptor for G-protein, and change receptor/G-protein coupling efficiency. When combined with molecular modeling and data from physical measurements, we anticipate that our experiments will provide empirical data defining the structural basis of ligand binding and activation of a muscarinic receptor.

Agency
National Institute of Health (NIH)
Institute
National Institute of General Medical Sciences (NIGMS)
Type
Research Project (R01)
Project #
1R01GM052737-01
Application #
2191874
Study Section
Molecular, Cellular, and Developmental Neurobiology Review Committee (MCDN)
Project Start
1995-01-01
Project End
1997-12-31
Budget Start
1995-01-01
Budget End
1995-12-31
Support Year
1
Fiscal Year
1995
Total Cost
Indirect Cost
Name
University of Vermont & St Agric College
Department
Psychiatry
Type
Schools of Medicine
DUNS #
066811191
City
Burlington
State
VT
Country
United States
Zip Code
05405
Spalding, Tracy A; Trotter, Carol; Skjaerbaek, Niels et al. (2002) Discovery of an ectopic activation site on the M(1) muscarinic receptor. Mol Pharmacol 61:1297-302
Burstein, E S; Spalding, T A; Brann, M R (1998) Structure/function relationships of a G-protein coupling pocket formed by the third intracellular loop of the m5 muscarinic receptor. Biochemistry 37:4052-8
Spalding, T A; Burstein, E S; Henderson, S C et al. (1998) Identification of a ligand-dependent switch within a muscarinic receptor. J Biol Chem 273:21563-8
Burstein, E S; Brauner-Osborne, H; Spalding, T A et al. (1997) Interactions of muscarinic receptors with the heterotrimeric G proteins Gq and G12: transduction of proliferative signals. J Neurochem 68:525-33
Burstein, E S; Spalding, T A; Brann, M R (1997) Pharmacology of muscarinic receptor subtypes constitutively activated by G proteins. Mol Pharmacol 51:312-9
Spalding, T A; Burstein, E S; Wells, J W et al. (1997) Constitutive activation of the m5 muscarinic receptor by a series of mutations at the extracellular end of transmembrane 6. Biochemistry 36:10109-16
Burstein, E S; Spalding, T A; Brann, M R (1996) Constitutive activation of chimeric m2/m5 muscarinic receptors and delineation of G-protein coupling selectivity domains. Biochem Pharmacol 51:539-44
Hill-Eubanks, D; Burstein, E S; Spalding, T A et al. (1996) Structure of a G-protein-coupling domain of a muscarinic receptor predicted by random saturation mutagenesis. J Biol Chem 271:3058-65
Spalding, T A; Burstein, E S; Brauner-Osborne, H et al. (1995) Pharmacology of a constitutively active muscarinic receptor generated by random mutagenesis. J Pharmacol Exp Ther 275:1274-9